Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression. May 1, 2015
Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia April 20, 2015
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review April 13, 2015
